ARCHIVES

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

This article is from The Cancer Letter archive.

Vol. 37 No. 14 | April 8, 2011

Download PDF Visit The Full Archive

Related Articles

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

DCPC Plans Future RFAs, But Most Will Depend n bypass Budget

June 22, 1990

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991